Abstract

Several species of Globisporangium and Pythium cause cavity spot of carrot. Disease management in conventional production relies primarily on applications of the fungicide mefenoxam. Growers’ reports in Ontario, Canada of severe cavity spot, even when using mefenoxam applications, suggests mefenoxam resistance may be prevalent in pathogen populations in this region. The objectives of the study were to develop a rapid and accurate optical density (OD) assay to assess mefenoxam sensitivity of 188 isolates of Globisporangium and Pythium species collected from 13 carrot fields in Ontario from 2020 to 2023. The isolates belonged to seven species: G. intermedium, G. irregulare, G. rostratifingens, G. sylvaticum, G. ultimum, G. violae, and P. sulcatum. The OD was measured at 600 nm in broth amended at different concentrations of mefenoxam, with OD readings at nine positions per well in a 96-well plate. The OD assay was validated by comparing EC50 values with a standard fungicide-amended agar medium assay using 20 representative isolates. There was a significant linear relationship (R2 = 0.97, P = <0.0001) between the two assays. Of the 188 isolates tested, 24% exhibited <60% inhibition of mycelial growth at 5 μg mefenoxam mL-1, 50% were inhibited by >60% at 5 μg mL-1, 19% were inhibited by >60% at 1 μg mL-1, and 7% were inhibited >60% even at 0.1 μg mL-1. The OD assay proved to be efficient, rapid, and accurate for monitoring mefenoxam sensitivity of these oomycetes.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.